Dr. Sarah Mitchell
Dr. Sarah Mitchell is a physical therapist specializing in c…
Regenerative medicine aims to move beyond symptom management by supporting tissue repair or changing the local healing environment. For musculoskeletal pain, the two approaches readers often encounter are Platelet-Rich Plasma (PRP) and Mesenchymal Stem Cell (MSC) interventions. Both have generated interest, but they sit at different points on the evidence and regulatory spectrum.
How PRP Therapy Works
PRP therapy involves drawing your own blood, centrifuging it to concentrate platelets, and injecting the resulting plasma into a target joint or tendon. The goal is to influence local healing and inflammation, not to guarantee tissue regeneration.
What Makes Platelets Special Platelets contain bioactive proteins such as platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-beta), and vascular endothelial growth factor (VEGF). These factors may influence inflammation, cell signaling, and tissue remodeling, but the clinical effect depends heavily on the condition being treated and the preparation used.
The Evidence: Where PRP Shines
Rotator Cuff Tendinopathy Some systematic reviews suggest PRP can improve pain and function for certain tendon conditions, including some rotator cuff problems. Comparisons with corticosteroid injections vary by study design, PRP preparation, and follow-up period, so it is better viewed as a possible option for selected patients rather than a reliably better treatment.
Knee Osteoarthritis Reviews of PRP for knee osteoarthritis often report improvements in pain and function, especially in mild-to-moderate cases, but protocols are not standardized and results are not uniform. Long-term advantages over other injections remain uncertain in some analyses.
How PRP Differs From Corticosteroid Shots Corticosteroid injections are commonly used for short-term inflammation and pain relief, but repeated injections may not be appropriate for every joint or tendon. PRP is intended to influence healing biology rather than simply suppress inflammation, but that does not mean it reliably rebuilds cartilage or replaces standard care.
Mesenchymal Stem Cell Therapy: The Next Frontier
MSC interventions may be marketed as coming from adipose tissue, bone marrow aspirate concentrate (BMAC), or donor-derived tissue sources. They are being studied for possible effects on inflammation and tissue repair, but claims that they rebuild cartilage or cure arthritis should be treated with caution.
Adipose vs. Bone Marrow Sources Current comparative evidence is still evolving. Different cell sources, processing methods, doses, and patient populations make studies hard to compare, and many marketed stem cell interventions for arthritis are not FDA-approved.
Current Limitations Broad clinical implementation of MSC therapy faces significant hurdles: - **Extreme methodological heterogeneity** across clinical trials makes comparison difficult - **Exceptionally high procedural costs** ($3,000–$10,000+ per treatment) - **Stringent, evolving regulatory oversight** regarding manipulation of human cellular tissue - **Variable quality control** between clinics and preparation methods
What a Typical PRP Treatment Looks Like
The Procedure 1. Blood draw (usually 30–60 mL from your arm) 2. Centrifugation (15–20 minutes to separate and concentrate platelets) 3. Ultrasound-guided injection into the target joint or tendon 4. Brief recovery period (1–3 days of mild soreness)
Timeline for Results - **Weeks 1–2**: Mild soreness from the injection (this is normal — the growth factors are triggering an inflammatory healing response) - **Weeks 4–6**: Initial improvement in pain and function - **Months 3–6**: Peak benefits, particularly for tendon injuries - **Months 6–12**: Benefits may gradually diminish; repeat treatments are often recommended
The Cost Question
PRP treatments typically range from $500–$2,000 per injection and are rarely covered by insurance (considered experimental by most insurers). However, when weighed against the cost of ongoing medication, physical therapy, and potential surgery, many patients find the investment worthwhile.
Who Is a Good Candidate?
PRP may be considered by some clinicians for:
- Mild to moderate osteoarthritis (Kellgren-Lawrence grades 1–3)
- Chronic tendon injuries (rotator cuff, tennis elbow, Achilles)
- Patients who have failed conservative treatment but want to avoid or delay surgery
- Active individuals looking for options after a careful diagnosis
Who Should Be Cautious - Patients with severe, bone-on-bone arthritis (limited cartilage to regenerate) - Those with active infections or blood disorders - Patients on blood thinners (consult your physician about timing)
Red Flags: What to Watch For
The regenerative medicine field includes reputable clinicians and research programs, but it has also attracted unproven clinics. Be cautious of:
- Claims of "curing" arthritis or guaranteed results
- Claims that a stem cell product is FDA-approved for arthritis or general joint repair
- Clinics that don't use image-guided (ultrasound) injection
- Providers who can't explain their centrifugation protocol
- Treatments at dramatically low prices (quality control matters)
The Bottom Line
PRP may have a role for selected musculoskeletal conditions, particularly some tendon problems and mild-to-moderate osteoarthritis, but protocols and results vary. Stem cell interventions for arthritis remain earlier in the evidence journey and require extra caution because many marketed uses are not FDA-approved. Careful patient selection, realistic expectations, and a qualified clinician matter.